Institute of Pediatrics, Children's Hospital of Fudan University, State Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Department of Obstetrics and Gynecology, Center of Reproductive Medicine, Shengjing Hospital, China Medical University, Shenyang, 110004, China.
J Assist Reprod Genet. 2024 May;41(5):1233-1243. doi: 10.1007/s10815-024-03071-3. Epub 2024 Mar 27.
Abnormalities in oocyte maturation, fertilization, and early embryonic development are major causes of primary infertility in women who are undergoing IVF/ICSI attempts. Although many genetic factors responsible for these abnormal phenotypes have been identified, there are more additional pathogenic genes and variants yet to be discovered. Previous studies confirmed that bi-allelic PATL2 deficiency is an important factor for female infertility. In this study, 935 infertile patients with IVF/ICSI failure were selected for whole-exome sequencing, and 18 probands carrying PATL2 variants with a recessive inheritance pattern were identified.
We estimated that the prevalence contributed by PATL2 was 1.93% (18/935) in our study cohort.
15 novel variants were found in those families, including c.1093C > T, c.1609dupA, c.1204C > T, c.643dupG, c.877-2A > G, c.1228C > G, c.925G > A, c.958G > A, c.4A > G, c.1258T > C, c.1337G > A, c.1264dupA, c.88G > T, c.1065-2A > G, and c.1271T > C. The amino acids altered by the corresponding variants were highly conserved in mammals, and in silico analysis and 3D molecular modeling suggested that the PATL2 mutants impaired the physiologic function of the resulting proteins. Diverse clinical phenotypes, including oocyte maturation defect, fertilization failure, and early embryonic arrest might result from different variants of PATL2.
These results expand the spectrum of PATL2 variants and provide an important reference for genetic counseling for female infertility, and they increase our understanding of the mechanisms of oocyte maturation arrest caused by PATL2 deficiency.
卵母细胞成熟、受精和早期胚胎发育异常是接受体外受精/卵胞浆内单精子注射(IVF/ICSI)尝试的女性原发性不孕的主要原因。尽管已经确定了许多导致这些异常表型的遗传因素,但还有更多的致病基因和变异有待发现。先前的研究证实,双等位基因 PATL2 缺乏是女性不孕的重要因素。在这项研究中,选择了 935 名 IVF/ICSI 失败的不孕患者进行全外显子组测序,发现了 18 个具有隐性遗传模式的 PATL2 变异的先证者。
我们估计在我们的研究队列中,PATL2 的患病率为 1.93%(18/935)。
在这些家庭中发现了 15 个新的变异,包括 c.1093C>T、c.1609dupA、c.1204C>T、c.643dupG、c.877-2A>G、c.1228C>G、c.925G>A、c.958G>A、c.4A>G、c.1258T>C、c.1337G>A、c.1264dupA、c.88G>T、c.1065-2A>G 和 c.1271T>C。相应变异所改变的氨基酸在哺乳动物中高度保守,计算机分析和 3D 分子建模表明,PATL2 突变体损害了由此产生的蛋白质的生理功能。不同的临床表型,包括卵母细胞成熟缺陷、受精失败和早期胚胎停滞,可能是由 PATL2 的不同变异引起的。
这些结果扩展了 PATL2 变异谱,为女性不孕的遗传咨询提供了重要参考,并加深了我们对 PATL2 缺乏引起卵母细胞成熟阻滞机制的理解。